1-8 of 8
Michelle A. Rudek
Close
Sort by
Journal Articles

A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Leukemias

Ivana Gojo, MD, Jan H. Beumer, PharmD, PhD, Keith Pratz, MD, Jiuping Ji, Lihua Wang, PhD, Michelle A. Rudek, PharmD, PhD, Michael A. McDevitt, MD PhD, Maria R. Baer, MD, Amanda Blackford, ScM, B. Douglas Smith, MD, Steven D. Gore, MD, Hetty E. Carraway, MD MBA, Margaret M. Showel, MD, Mark J. Levis, MD PhD, Amy E. DeZern, MD MHS, Douglas Gladstone, MD, Tania Jain, MD, Jackie Greer, RN, Marie Pouquet, PharmD, Ali-walbi Ismail, PharmD, MS, James Herman, MD, Weijie Poh, PhD, Larry Karnitz, PhD, Scott H. Kaufmann, MD PhD, Alice Chen, MD, Judith E Karp, MD
Journal: Blood
Blood (2015) 126 (23): 1361.
https://doi.org/10.1182/blood.V126.23.1361.1361
Published: 2015
Journal Articles

Prospective Study of Peri-Transplant Use of Sorafenib As Remission Maintenance for FLT3-ITD Patients Undergoing Allogeneic Transplantation

Keith W. Pratz, MD, Ivana Gojo, MD, Judith E. Karp, MD, Leo Luznik, MD, B. Douglas Smith, MD, Richard J Jones, MD, Jackie Greer, RN, Christopher Gocke, MD, Maria R. Baer, MD, Vu H. Duong, MD, John J Wright, MD PhD, Michelle A. Rudek, PharmD, PhD, Ashkan Emadi, MD, PhD, Mark J. Levis, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3164.
https://doi.org/10.1182/blood.V126.23.3164.3164
Published: 2015
Journal Articles

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with FLT3-ITD AML

Yi-Bin Chen, MD, Li Shuli, PhD, Lane A. Andrew, MDPhD, Christine Connolly, Candice Del Rio, NP, Betsy Valles, NP, Morgan Curtis, Karen K. Ballen, MD, Corey S Cutler, MD MPH, Bimalangshu R Dey, MD, Areej El-Jawahri, MD, Amir T. Fathi, MD, Vincent T Ho, MD, Amy Joyce, NP, Steven L. McAfee, MD, Michelle A Rudek, Trivikram Rajkhowa, Sigitas Verselis, PhD, Joseph H. Antin, MD, Thomas R. Spitzer, MD, Mark Levis, MD PhD, Robert J. Soiffer, MD
Journal: Blood
Blood (2014) 124 (21): 671.
https://doi.org/10.1182/blood.V124.21.671.671
Published: 2014
Journal Articles

AMC075: The Combination of Vorinostat with Chemotherapy and Rituximab Is Tolerable and Feasible in HIV-Related B-Cell Non-Hodgkin’s Lymphoma with High-Risk Features

Juan Carlos Ramos, MD, Joseph Sparano, MD, Page Moore, Jeannette Y. Lee, Michelle A Rudek, Richard F. Ambinder, Ethel Cesarman, MD PhD, Ariela Noy, MD, Ronald T. Mitsuyasu, MD
Journal: Blood
Blood (2014) 124 (21): 4473.
https://doi.org/10.1182/blood.V124.21.4473.4473
Published: 2014
Journal Articles

Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT -3 internal tandem duplication mutation

Clinical Trials & Observations
Farhad Ravandi, Mona Lisa Alattar, Michael R. Grunwald, Michelle A. Rudek, Trivikram Rajkhowa, Mary Ann Richie, Sherry Pierce, Naval Daver, Guillermo Garcia-Manero, Stefan Faderl, Aziz Nazha, Marina Konopleva, Gautam Borthakur, Jan Burger, Tapan Kadia, Sara Dellasala, Michael Andreeff, Jorge Cortes, Hagop Kantarjian, Mark Levis
Journal: Blood
Blood (2013) 121 (23): 4655–4662.
https://doi.org/10.1182/blood-2013-01-480228
Published: 2013
Includes: Supplemental data
Journal Articles

Phase I Trial of the Oral Poly (ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888, V) Combined Wtih Topoecan (T) and Carboplatin (C) for Adults with Relapsed and Refractory Acute Leukemias,

Keith W. Pratz, MD, Scott H. Kaufmann, MD, PhD, Mark R. Litzow, MD, Jiuping Ji, PhD, Alice Chen, MD, Michelle A Rudek, Judith E. Karp, MD
Journal: Blood
Blood (2011) 118 (21): 3634.
https://doi.org/10.1182/blood.V118.21.3634.3634
Published: 2011
Journal Articles

Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias

Clinical Trials & Observations
Judith E. Karp, B. Douglas Smith, Linda S. Resar, Jacqueline M. Greer, Amanda Blackford, Ming Zhao, Dwella Moton-Nelson, Katrina Alino, Mark J. Levis, Steven D. Gore, Biju Joseph, Hetty Carraway, Michael A. McDevitt, Lorena Bagain, Karen Mackey, Janet Briel, L. Austin Doyle, John J. Wright, Michelle A. Rudek
Journal: Blood
Blood (2011) 117 (12): 3302–3310.
https://doi.org/10.1182/blood-2010-09-310862
Published: 2011
Journal Articles

Pharmacokinetics and Safety of Bortezomib In Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction: Results of the Phase 1 National Cancer Institute Organ Dysfunction Working Group Study NCI 6432

Karthik Venkatakrishnan, Ramesh K Ramanathan, John Sarantopoulos, Daniel L Mulkerin, Stephen I Shibata, Anne Hamilton, Afshin Dowlati, Sridhar Mani, Michelle A Rudek, Percy Ivy, Chris H Takimoto, Rachel Neuwirth, Sudha Parasuraman, Patricia M LoRusso
Journal: Blood
Blood (2010) 116 (21): 3975.
https://doi.org/10.1182/blood.V116.21.3975.3975
Published: 2010